Q32 Bio (QTTB) Shares Outstanding (2017 - 2026)
Q32 Bio (QTTB) posted quarterly Shares Outstanding (Entity) of $14.6 million for Q1 2026, up 19.94% year-over-year from $12.2 million in Q1 2025, and up 13.78% quarter-over-quarter from $12.9 million in Q4 2025.
Q32 Bio (QTTB) Shares Outstanding (2017 - 2026) Analysis & Trends
Q32 Bio's Shares Outstanding (Entity) history runs 10 years deep, the most recent figure standing at $14.6 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 19.94% year-over-year to $14.6 million; the TTM figure through Mar 2026 stood at $14.6 million (up 19.94% YoY), while the FY2025 annual figure was $12.9 million, up 37.95% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $14.6 million, up from $12.9 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $14.6 million in Q1 2026, with the low at $995280.0 in Q1 2024.
- The 5-year median for Shares Outstanding (Entity) is $3.2 million (2023), against an average of $7.3 million.
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) plunged 69.0% in 2024, then surged 1125.55% in 2025.
- Q32 Bio's Shares Outstanding (Entity) stood at $3.2 million in 2022, then advanced by 0.61% to $3.2 million in 2023, then jumped by 190.07% to $9.3 million in 2024, then soared by 37.95% to $12.9 million in 2025, then rose by 13.78% to $14.6 million in 2026.
- Business Quant data shows QTTB's Shares Outstanding (Entity) at $14.6 million in Q1 2026, $12.9 million in Q4 2025, and $12.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Q32 Bio | 359.61 Mn | 253.31 Mn | - | 20.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.34 Mn |
| Mar 31, 2026 | 14.10 Mn |
| Dec 31, 2025 | 12.30 Mn |
| Sep 30, 2025 | 12.24 Mn |
| Jun 30, 2025 | 12.20 Mn |
| Mar 31, 2025 | 12.20 Mn |
| Dec 31, 2024 | 9.32 Mn |
| Sep 30, 2024 | 12.08 Mn |
| Jun 30, 2024 | 11.96 Mn |
| Mar 31, 2024 | 995,280.00 |
| Dec 31, 2023 | 3.21 Mn |
| Sep 30, 2023 | 3.21 Mn |
| Jun 30, 2023 | 3.21 Mn |
| Mar 31, 2023 | 3.21 Mn |
| Dec 31, 2022 | 3.19 Mn |
| Sep 30, 2022 | 3.19 Mn |
| Jun 30, 2022 | 3.19 Mn |
| Mar 31, 2022 | 3.18 Mn |
| Dec 31, 2021 | 3.07 Mn |
| Sep 30, 2021 | 3.17 Mn |